Barkley Pharmacology Practice Exam — 150 High-
Yield Questions with Detailed Answer Explanations
and Rationales
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
Question 1
A 72-year-old patient is prescribed a medication that undergoes
extensive first-pass metabolism. Which route of administration would
bypass this effect?
A. Oral
B. Sublingual
C. Rectal
D. Enteral
Correct Answer: B
Rationale: Sublingual administration bypasses the hepatic first-pass
effect because the medication is absorbed directly into the systemic
circulation through the venous drainage of the oral mucosa. Oral
and enteral routes undergo first-pass metabolism. Rectal
administration partially bypasses first-pass metabolism but is not
as complete as sublingual.
Question 2
Which pharmacokinetic parameter describes the fraction of an
,administered drug dose that reaches systemic circulation unchanged?
A. Volume of distribution
B. Clearance
C. Bioavailability
D. Half-life
Correct Answer: C
Rationale: Bioavailability (F) is the fraction of an administered dose
that reaches systemic circulation in an unchanged form.
Intravenous administration has 100% bioavailability. Volume of
distribution describes the apparent space in which a drug
distributes. Clearance describes the rate of drug removal from
plasma. Half-life is the time required for plasma concentration to
decrease by 50%.
Question 3
A patient with chronic kidney disease is prescribed a medication that is
primarily renally excreted. Which adjustment is most appropriate?
A. Increase the dose
B. Decrease the dose or extend the dosing interval
C. Administer the medication intravenously
D. Add a second medication to enhance elimination
Correct Answer: B
Rationale: For renally excreted drugs in patients with chronic kidney
disease, dose reduction or interval extension is required to prevent
,accumulation and toxicity. Increasing the dose or adding another
medication would worsen the problem.
Question 4
A 65-year-old patient is taking warfarin. Which cytochrome P450 enzyme
is primarily responsible for warfarin metabolism?
A. CYP2D6
B. CYP3A4
C. CYP2C9
D. CYP1A2
Correct Answer: C
Rationale: Warfarin is primarily metabolized by CYP2C9. Genetic
polymorphisms in CYP2C9 can affect warfarin dosing and bleeding
risk. CYP3A4 metabolizes many medications but is not the primary
enzyme for warfarin.
Question 5
Which of the following best describes the therapeutic index of a drug?
A. The ratio of the toxic dose to the therapeutic dose
B. The time required for a drug to reach steady state
C. The percentage of drug bound to plasma proteins
D. The rate of drug absorption from the gastrointestinal tract
Correct Answer: A
Rationale: The therapeutic index (TI) is the ratio of the toxic dose
(TD50) to the therapeutic dose (ED50). A narrow therapeutic index
, (e.g., warfarin, digoxin, lithium) indicates a small margin between
therapeutic and toxic effects, requiring close monitoring.
Question 6
A patient is started on a medication with a half-life of 12 hours.
Approximately how long will it take to reach steady state?
A. 12 hours
B. 24 hours
C. 48-60 hours
D. 72-84 hours
Correct Answer: C
Rationale: Steady state is typically reached after 4-5 half-lives. For
a half-life of 12 hours, steady state is reached in 48-60 hours.
Question 7
Which of the following describes a drug's volume of distribution (Vd)?
A. The rate of drug elimination
B. The apparent space in which a drug distributes
C. The fraction of drug absorbed
D. The time to peak concentration
Correct Answer: B
Rationale: Volume of distribution (Vd) is the apparent space in which
a drug distributes. A large Vd indicates extensive tissue distribution;
a small Vd indicates confinement to the vascular space.
Yield Questions with Detailed Answer Explanations
and Rationales
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
Question 1
A 72-year-old patient is prescribed a medication that undergoes
extensive first-pass metabolism. Which route of administration would
bypass this effect?
A. Oral
B. Sublingual
C. Rectal
D. Enteral
Correct Answer: B
Rationale: Sublingual administration bypasses the hepatic first-pass
effect because the medication is absorbed directly into the systemic
circulation through the venous drainage of the oral mucosa. Oral
and enteral routes undergo first-pass metabolism. Rectal
administration partially bypasses first-pass metabolism but is not
as complete as sublingual.
Question 2
Which pharmacokinetic parameter describes the fraction of an
,administered drug dose that reaches systemic circulation unchanged?
A. Volume of distribution
B. Clearance
C. Bioavailability
D. Half-life
Correct Answer: C
Rationale: Bioavailability (F) is the fraction of an administered dose
that reaches systemic circulation in an unchanged form.
Intravenous administration has 100% bioavailability. Volume of
distribution describes the apparent space in which a drug
distributes. Clearance describes the rate of drug removal from
plasma. Half-life is the time required for plasma concentration to
decrease by 50%.
Question 3
A patient with chronic kidney disease is prescribed a medication that is
primarily renally excreted. Which adjustment is most appropriate?
A. Increase the dose
B. Decrease the dose or extend the dosing interval
C. Administer the medication intravenously
D. Add a second medication to enhance elimination
Correct Answer: B
Rationale: For renally excreted drugs in patients with chronic kidney
disease, dose reduction or interval extension is required to prevent
,accumulation and toxicity. Increasing the dose or adding another
medication would worsen the problem.
Question 4
A 65-year-old patient is taking warfarin. Which cytochrome P450 enzyme
is primarily responsible for warfarin metabolism?
A. CYP2D6
B. CYP3A4
C. CYP2C9
D. CYP1A2
Correct Answer: C
Rationale: Warfarin is primarily metabolized by CYP2C9. Genetic
polymorphisms in CYP2C9 can affect warfarin dosing and bleeding
risk. CYP3A4 metabolizes many medications but is not the primary
enzyme for warfarin.
Question 5
Which of the following best describes the therapeutic index of a drug?
A. The ratio of the toxic dose to the therapeutic dose
B. The time required for a drug to reach steady state
C. The percentage of drug bound to plasma proteins
D. The rate of drug absorption from the gastrointestinal tract
Correct Answer: A
Rationale: The therapeutic index (TI) is the ratio of the toxic dose
(TD50) to the therapeutic dose (ED50). A narrow therapeutic index
, (e.g., warfarin, digoxin, lithium) indicates a small margin between
therapeutic and toxic effects, requiring close monitoring.
Question 6
A patient is started on a medication with a half-life of 12 hours.
Approximately how long will it take to reach steady state?
A. 12 hours
B. 24 hours
C. 48-60 hours
D. 72-84 hours
Correct Answer: C
Rationale: Steady state is typically reached after 4-5 half-lives. For
a half-life of 12 hours, steady state is reached in 48-60 hours.
Question 7
Which of the following describes a drug's volume of distribution (Vd)?
A. The rate of drug elimination
B. The apparent space in which a drug distributes
C. The fraction of drug absorbed
D. The time to peak concentration
Correct Answer: B
Rationale: Volume of distribution (Vd) is the apparent space in which
a drug distributes. A large Vd indicates extensive tissue distribution;
a small Vd indicates confinement to the vascular space.
